North America Microbiome Therapeutics Market by Manufacturers, Countries, Type and Application, Forecast to 2023

Publisher Name :
Date: 09-Mar-2018
No. of pages: 107

The human microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. Because of their small size, however, microorganisms make up only about 1 to 3 percent of our body mass (that's 2 to 6 pounds of bacteria in a 200-pound adult).

Scope of the Report:

This report focuses on the Microbiome Therapeutics in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application.

Market Segment by Manufacturers, this report covers

- Seres Therapeutics

- Assembly Biosciences

- Synthetic Biologics

- Interxon

- PureTech

- Synlogic

- Enterome BioScience

- 4D Pharma

- Second Genome

- AOBiome

- C3 Jian

- Rebiotix

- MicroBiome Therapeutics LLC

- Metabiomics

- Ritter Pharmaceuticals

- Symberix

- OpenBiome

- Azitra

- Symbiotix Biotherapies

- Osel

- Metabogen

Market Segment by Countries, covering

Market Segment by Type, covers

- C. difficile Infection (CDI)

- Inflammatory Bowel Disease (IBD)

- Orphan Drug

- Immuno-oncology

- Others

Market Segment by Applications, can be divided into

- C. difficile Infection (CDI)

- Inflammatory Bowel Disease (IBD)

- Orphan Drug

- Immuno-oncology

- Others

There are 15 Chapters to deeply display the North America Microbiome Therapeutics market.

Chapter 1, to describe Microbiome Therapeutics Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Microbiome Therapeutics, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Microbiome Therapeutics, for each country, from 2013 to 2018;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2013 to 2018;

Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications;

Chapter 10, Microbiome Therapeutics market forecast, by countries, type and application, with sales, price and revenue, from 2018 to 2023;

Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 13, to describe sales channel, distributors, traders, dealers etc.

Chapter 14 and 15, to describe Microbiome Therapeutics Research Findings and Conclusion, Appendix, methodology and data source

North America Microbiome Therapeutics Market by Manufacturers, Countries, Type and Application, Forecast to 2023

Table of Contents

1 Market Overview
1.1 Microbiome Therapeutics Introduction
1.2 Market Analysis by Type
1.3 Market Analysis by Applications
1.3.1 C. difficile Infection (CDI)
1.3.2 Inflammatory Bowel Disease (IBD)
1.3.3 Orphan Drug
1.3.4 Immuno-oncology
1.3.5 Others
1.4 Market Analysis by Countries
1.4.1 United States Status and Prospect (2013-2023)
1.4.2 Mexico Status and Prospect (2013-2023)
1.4.3 Canada Status and Prospect (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Seres Therapeutics
2.1.1 Business Overview
2.1.2 Microbiome Therapeutics Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Seres Therapeutics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Assembly Biosciences
2.2.1 Business Overview
2.2.2 Microbiome Therapeutics Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Assembly Biosciences Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Synthetic Biologics
2.3.1 Business Overview
2.3.2 Microbiome Therapeutics Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Synthetic Biologics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Interxon
2.4.1 Business Overview
2.4.2 Microbiome Therapeutics Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Interxon Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 PureTech
2.5.1 Business Overview
2.5.2 Microbiome Therapeutics Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 PureTech Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Synlogic
2.6.1 Business Overview
2.6.2 Microbiome Therapeutics Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Synlogic Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Enterome BioScience
2.7.1 Business Overview
2.7.2 Microbiome Therapeutics Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Enterome BioScience Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 4D Pharma
2.8.1 Business Overview
2.8.2 Microbiome Therapeutics Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 4D Pharma Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Second Genome
2.9.1 Business Overview
2.9.2 Microbiome Therapeutics Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 Second Genome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 AOBiome
2.10.1 Business Overview
2.10.2 Microbiome Therapeutics Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 AOBiome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 C3 Jian
2.11.1 Business Overview
2.11.2 Microbiome Therapeutics Type and Applications
2.11.2.1 Type 1
2.11.2.2 Type 2
2.11.3 C3 Jian Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Rebiotix
2.12.1 Business Overview
2.12.2 Microbiome Therapeutics Type and Applications
2.12.2.1 Type 1
2.12.2.2 Type 2
2.12.3 Rebiotix Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 MicroBiome Therapeutics LLC
2.13.1 Business Overview
2.13.2 Microbiome Therapeutics Type and Applications
2.13.2.1 Type 1
2.13.2.2 Type 2
2.13.3 MicroBiome Therapeutics LLC Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Metabiomics
2.14.1 Business Overview
2.14.2 Microbiome Therapeutics Type and Applications
2.14.2.1 Type 1
2.14.2.2 Type 2
2.14.3 Metabiomics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Ritter Pharmaceuticals
2.15.1 Business Overview
2.15.2 Microbiome Therapeutics Type and Applications
2.15.2.1 Type 1
2.15.2.2 Type 2
2.15.3 Ritter Pharmaceuticals Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Symberix
2.16.1 Business Overview
2.16.2 Microbiome Therapeutics Type and Applications
2.16.2.1 Type 1
2.16.2.2 Type 2
2.16.3 Symberix Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 OpenBiome
2.17.1 Business Overview
2.17.2 Microbiome Therapeutics Type and Applications
2.17.2.1 Type 1
2.17.2.2 Type 2
2.17.3 OpenBiome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18 Azitra
2.18.1 Business Overview
2.18.2 Microbiome Therapeutics Type and Applications
2.18.2.1 Type 1
2.18.2.2 Type 2
2.18.3 Azitra Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.19 Symbiotix Biotherapies
2.19.1 Business Overview
2.19.2 Microbiome Therapeutics Type and Applications
2.19.2.1 Type 1
2.19.2.2 Type 2
2.19.3 Symbiotix Biotherapies Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.20 Osel
2.20.1 Business Overview
2.20.2 Microbiome Therapeutics Type and Applications
2.20.2.1 Type 1
2.20.2.2 Type 2
2.20.3 Osel Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.21 Metabogen
2.21.1 Business Overview
2.2.2 Microbiome Therapeutics Type and Applications
2.21.2.1 Type 1
2.21.2.2 Type 2
2.21.3 Metabogen Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 North America Microbiome Therapeutics Market Competition, by Manufacturer
3.1 North America Microbiome Therapeutics Sales and Market Share by Manufacturer (2016-2017)
3.1.1 North America Microbiome Therapeutics Sales by Manufacturer (2016-2017)
3.1.2 North America Microbiome Therapeutics Sales Market Share by Manufacturer (2016-2017)
3.2 North America Microbiome Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
3.2.1 North America Microbiome Therapeutics Revenue by Manufacturer (2016-2017)
3.2.2 North America Microbiome Therapeutics Revenue Market Share by Manufacturer (2016-2017)
3.3 North America Microbiome Therapeutics Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Microbiome Therapeutics Manufacturer Market Share (2016-2017)
3.4.2 Top 5 Microbiome Therapeutics Manufacturer Market Share (2016-2017)
3.5 Market Competition Trend
4 North America Microbiome Therapeutics Market Analysis by Countries
4.1 North America Microbiome Therapeutics Sales and Market Share by Countries (2013-2018)
4.1.1 North America Microbiome Therapeutics Sales by Countries (2013-2018)
4.1.2 North America Microbiome Therapeutics Sales Market Share by Countries (2013-2018)
4.2 North America Microbiome Therapeutics Revenue (Value) and Market Share by Countries (2013-2018)
4.2.1 North America Microbiome Therapeutics Revenue by Countries (2013-2018)
4.2.2 North America Microbiome Therapeutics Revenue Market Share by Countries (2013-2018)
5 North America Market Segmentation Microbiome Therapeutics by Type
5.1 North America Microbiome Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
5.1.1 North America Microbiome Therapeutics Sales and Market Share by Type (2013-2018)
5.1.2 North America Microbiome Therapeutics Revenue and Market Share by Type (2013-2018)
5.2 Type 1 Sales Growth Rate and Price
6 North America Market Segmentation Microbiome Therapeutics by Application
6.1 North America Microbiome Therapeutics Sales Market Share by Application (2013-2018)
6.2 C. difficile Infection (CDI) Sales Growth (2013-2018)
6.3 Inflammatory Bowel Disease (IBD) Sales Growth (2013-2018)
6.4 Orphan Drug Sales Growth (2013-2018)
6.5 Immuno-oncology Sales Growth (2013-2018)
6.6 Others Sales Growth (2013-2018)
7 United States Microbiome Therapeutics Sales, Revenue, by Type, Application and Manufacturers
7.1 United States Microbiome Therapeutics Revenue, Sales and Growth Rate (2013-2018)
7.2 United States Microbiome Therapeutics Sales and Market Share by Type
7.2.1 United States Microbiome Therapeutics Sales by Type (2013-2018)
7.2.2 United States Microbiome Therapeutics Sales Market Share by Type (2013-2018)
7.3 United States Microbiome Therapeutics Sales and Market Share by Application (2013-2018)
7.3.1 United States Microbiome Therapeutics Sales by Application (2013-2018)
7.3.2 United States Microbiome Therapeutics Sales Market Share by Application (2013-2018)
7.4 United States Microbiome Therapeutics Sales, Revenue and Market Share by Manufacturer (2016-2017)
7.4.1 United States Microbiome Therapeutics Sales and Market Share by Manufacturer (2016-2017)
7.4.2 United States Microbiome Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
7.5 United States Microbiome Therapeutics Export and Import (2013-2018)
8 Canada Microbiome Therapeutics Sales, Revenue, by Type, Application and Manufacturers
8.1 Canada Microbiome Therapeutics Revenue, Sales and Growth Rate (2013-2018)
8.2 Canada Microbiome Therapeutics Sales and Market Share by Type (2013-2018)
8.2.1 Canada Microbiome Therapeutics Sales by Type (2013-2018)
8.2.2 Canada Microbiome Therapeutics Sales Market Share by Type (2013-2018)
8.3 Canada Microbiome Therapeutics Sales and Market Share by Application (2013-2018)
8.3.1 Canada Microbiome Therapeutics Sales by Application (2013-2018)
8.3.2 Canada Microbiome Therapeutics Sales Market Share by Application (2013-2018)
8.4 Canada Microbiome Therapeutics Sales, Revenue and Market Share by Manufacturer (2016-2017)
8.4.1 Canada Microbiome Therapeutics Sales and Market Share by Manufacturer (2016-2017)
8.4.2 Canada Microbiome Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
8.5 Canada Microbiome Therapeutics Export and Import (2013-2018)
9 Mexico Microbiome Therapeutics Sales, Revenue, by Type, Application and Manufacturers
9.1 Mexico Microbiome Therapeutics Revenue, Sales and Growth Rate (2013-2018)
9.2 Mexico Microbiome Therapeutics Sales and Market Share by Type (2013-2018)
9.2.1 Mexico Microbiome Therapeutics Sales by Type (2013-2018)
9.2.2 Mexico Microbiome Therapeutics Sales Market Share by Type (2013-2018)
9.3 Mexico Microbiome Therapeutics Sales and Market Share by Application (2013-2018)
9.3.1 Mexico Microbiome Therapeutics Sales by Application (2013-2018)
9.3.2 Mexico Microbiome Therapeutics Sales Market Share by Application (2013-2018)
9.4 Mexico Microbiome Therapeutics Sales, Revenue and Market Share by Manufacturer (2016-2017)
9.4.1 Mexico Microbiome Therapeutics Sales and Market Share by Manufacturer (2016-2017)
9.4.2 Mexico Microbiome Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
9.5 Mexico Microbiome Therapeutics Export and Import (2013-2018)
10 Microbiome Therapeutics Market Forecast (2018-2023)
10.1 North America Microbiome Therapeutics Sales, Revenue and Growth Rate (2018-2023)
10.2 Microbiome Therapeutics Market Forecast by Countries (2018-2023)
10.2.1 North America Microbiome Therapeutics Sales Forecast by Countries (2018-2023)
10.2.2 United States Microbiome Therapeutics Forecast (2018-2023)
10.2.3 Canada Microbiome Therapeutics Forecast (2018-2023)
10.2.4 Mexico Microbiome Therapeutics Forecast (2018-2023)
10.3 Microbiome Therapeutics Market Forecast by Type (2018-2023)
10.3.1 North America Microbiome Therapeutics Sales Forecast by Type (2018-2023)
10.3.2 North America Microbiome Therapeutics Market Share Forecast by Type (2018-2023)
10.4 Microbiome Therapeutics Market Forecast by Application (2018-2023)
10.4.1 North America Microbiome Therapeutics Sales Forecast by Application (2018-2023)
10.4.2 North America Microbiome Therapeutics Market Share Forecast by Application (2018-2023)
11 Microbiome Therapeutics Manufacturing Cost Analysis
11.1 Microbiome Therapeutics Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Microbiome Therapeutics
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Microbiome Therapeutics Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Microbiome Therapeutics Major Manufacturers in 2017
12.4 Downstream Buyers
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Microbiome Therapeutics Picture
Table Product Specifications of Microbiome Therapeutics
Figure North America Sales Market Share of Microbiome Therapeutics by Types in 2017
Table Types of Microbiome Therapeutics
Figure North America Microbiome Therapeutics Sales Market Share by Applications in 2017
Table Applications of Microbiome Therapeutics
Figure C. difficile Infection (CDI) Picture
Figure Inflammatory Bowel Disease (IBD) Picture
Figure Orphan Drug Picture
Figure Immuno-oncology Picture
Figure Others Picture
Figure United States Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Mexico Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Canada Microbiome Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Table Seres Therapeutics Basic Information, Manufacturing Base and Competitors
Table Seres Therapeutics Microbiome Therapeutics Type and Applications
Table Seres Therapeutics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Assembly Biosciences Basic Information, Manufacturing Base and Competitors
Table Assembly Biosciences Microbiome Therapeutics Type and Applications
Table Assembly Biosciences Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Synthetic Biologics Basic Information, Manufacturing Base and Competitors
Table Synthetic Biologics Microbiome Therapeutics Type and Applications
Table Synthetic Biologics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Interxon Basic Information, Manufacturing Base and Competitors
Table Interxon Microbiome Therapeutics Type and Applications
Table Interxon Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table PureTech Basic Information, Manufacturing Base and Competitors
Table PureTech Microbiome Therapeutics Type and Applications
Table PureTech Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Synlogic Basic Information, Manufacturing Base and Competitors
Table Synlogic Microbiome Therapeutics Type and Applications
Table Synlogic Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Enterome BioScience Basic Information, Manufacturing Base and Competitors
Table Enterome BioScience Microbiome Therapeutics Type and Applications
Table Enterome BioScience Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table 4D Pharma Basic Information, Manufacturing Base and Competitors
Table 4D Pharma Microbiome Therapeutics Type and Applications
Table 4D Pharma Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Second Genome Basic Information, Manufacturing Base and Competitors
Table Second Genome Microbiome Therapeutics Type and Applications
Table Second Genome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AOBiome Basic Information, Manufacturing Base and Competitors
Table AOBiome Microbiome Therapeutics Type and Applications
Table AOBiome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table C3 Jian Basic Information, Manufacturing Base and Competitors
Table C3 Jian Microbiome Therapeutics Type and Applications
Table C3 Jian Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Rebiotix Basic Information, Manufacturing Base and Competitors
Table Rebiotix Microbiome Therapeutics Type and Applications
Table Rebiotix Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table MicroBiome Therapeutics LLC Basic Information, Manufacturing Base and Competitors
Table MicroBiome Therapeutics LLC Microbiome Therapeutics Type and Applications
Table MicroBiome Therapeutics LLC Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Metabiomics Basic Information, Manufacturing Base and Competitors
Table Metabiomics Microbiome Therapeutics Type and Applications
Table Metabiomics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Ritter Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Ritter Pharmaceuticals Microbiome Therapeutics Type and Applications
Table Ritter Pharmaceuticals Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Symberix Basic Information, Manufacturing Base and Competitors
Table Symberix Microbiome Therapeutics Type and Applications
Table Symberix Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table OpenBiome Basic Information, Manufacturing Base and Competitors
Table OpenBiome Microbiome Therapeutics Type and Applications
Table OpenBiome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Azitra Basic Information, Manufacturing Base and Competitors
Table Azitra Microbiome Therapeutics Type and Applications
Table Azitra Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Symbiotix Biotherapies Basic Information, Manufacturing Base and Competitors
Table Symbiotix Biotherapies Microbiome Therapeutics Type and Applications
Table Symbiotix Biotherapies Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Osel Basic Information, Manufacturing Base and Competitors
Table Osel Microbiome Therapeutics Type and Applications
Table Osel Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Metabogen Basic Information, Manufacturing Base and Competitors
Table Metabogen Microbiome Therapeutics Type and Applications
Table Metabogen Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table North America Microbiome Therapeutics Sales by Manufacturer (2016-2017)
Table North America Microbiome Therapeutics Sales Market Share by Manufacturer (2016-2017)
Figure North America Microbiome Therapeutics Sales Market Share by Manufacturer in 2016
Figure North America Microbiome Therapeutics Sales Market Share by Manufacturer in 2017
Table North America Microbiome Therapeutics Revenue by Manufacturer (2016-2017)
Table North America Microbiome Therapeutics Revenue Market Share by Manufacturer (2016-2017)
Figure North America Microbiome Therapeutics Revenue Market Share by Manufacturer in 2016
Figure North America Microbiome Therapeutics Revenue Market Share by Manufacturer in 2017
Table North America Microbiome Therapeutics Price by Manufacturers (2016-2017)
Figure Top 3 Microbiome Therapeutics Manufacturer Market Share in 2016
Figure Top 3 Microbiome Therapeutics Manufacturer Market Share in 2017
Figure Top 5 Microbiome Therapeutics Manufacturer Market Share in 2016
Figure Top 5 Microbiome Therapeutics Manufacturer Market Share in 2017
Table North America Microbiome Therapeutics Sales by Countries (2013-2018)
Figure North America Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Table North America Microbiome Therapeutics Sales Market Share by Countries (2013-2018)
Figure North America 2013 Microbiome Therapeutics Sales Market Share by Countries
Figure North America 2017 Microbiome Therapeutics Sales Market Share by Countries
Table North America Microbiome Therapeutics Revenue by Countries (2013-2018)
Figure North America Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Table North America Microbiome Therapeutics Revenue Market Share by Countries (2013-2018)
Figure North America 2013 Microbiome Therapeutics Revenue Market Share by Countries
Figure North America 2017 Microbiome Therapeutics Revenue Market Share by Countries
Table North America Microbiome Therapeutics Sales by Type (2013-2018)
Table North America Microbiome Therapeutics Sales Share by Type (2013-2018)
Table North America Microbiome Therapeutics Revenue by Type (2013-2018)
Table North America Microbiome Therapeutics Revenue Share by Type (2013-2018)
Table North America Microbiome Therapeutics Sales by Application (2013-2018)
Table North America Microbiome Therapeutics Sales Share by Application (2013-2018)
Figure North America C. difficile Infection (CDI) Sales Growth (2013-2018)
Figure North America Inflammatory Bowel Disease (IBD) Sales Growth (2013-2018)
Figure North America Orphan Drug Sales Growth (2013-2018)
Figure North America Immuno-oncology Sales Growth (2013-2018)
Figure North America Others Sales Growth (2013-2018)
Figure United States Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Figure United States Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Table United States Microbiome Therapeutics Sales by Type (2013-2018)
Table United States Microbiome Therapeutics Sales Market Share by Type (2013-2018)
Table United States Microbiome Therapeutics Sales by Application (2013-2018)
Table United States Microbiome Therapeutics Sales Market Share by Application (2013-2018)
Table United States Microbiome Therapeutics Sales by Manufacturer (2016-2017)
Figure United States Microbiome Therapeutics Sales Market Share by Manufacturer in 2016
Figure United States Microbiome Therapeutics Sales Market Share by Manufacturer in 2017
Table United States Microbiome Therapeutics Revenue by Manufacturer (2016-2017)
Figure United States Microbiome Therapeutics Revenue Market Share by Manufacturer in 2016
Figure United States Microbiome Therapeutics Revenue Market Share by Manufacturer in 2017
Table United States Microbiome Therapeutics Export and Import (2013-2018)
Figure Canada Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Figure Canada Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Table Canada Microbiome Therapeutics Sales by Type (2013-2018)
Table Canada Microbiome Therapeutics Sales Market Share by Type (2013-2018)
Table Canada Microbiome Therapeutics Sales by Application (2013-2018)
Table Canada Microbiome Therapeutics Sales Market Share by Application (2013-2018)
Table Canada Microbiome Therapeutics Sales by Manufacturer (2016-2017)
Figure Canada Microbiome Therapeutics Sales Market Share by Manufacturer in 2016
Figure Canada Microbiome Therapeutics Sales Market Share by Manufacturer in 2017
Table Canada Microbiome Therapeutics Revenue by Manufacturer (2016-2017)
Figure Canada Microbiome Therapeutics Revenue Market Share by Manufacturer in 2016
Figure Canada Microbiome Therapeutics Revenue Market Share by Manufacturer in 2017
Table Canada Microbiome Therapeutics Export and Import (2013-2018)
Figure Mexico Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Figure Mexico Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Table Mexico Microbiome Therapeutics Sales by Type (2013-2018)
Table Mexico Microbiome Therapeutics Sales Market Share by Type (2013-2018)
Table Mexico Microbiome Therapeutics Sales by Application (2013-2018)
Table Mexico Microbiome Therapeutics Sales Market Share by Application (2013-2018)
Table Mexico Microbiome Therapeutics Sales by Manufacturer (2016-2017)
Figure Mexico Microbiome Therapeutics Sales Market Share by Manufacturer in 2016
Figure Mexico Microbiome Therapeutics Sales Market Share by Manufacturer in 2017
Table Mexico Microbiome Therapeutics Revenue by Manufacturer (2016-2017)
Figure Mexico Microbiome Therapeutics Revenue Market Share by Manufacturer in 2016
Figure Mexico Microbiome Therapeutics Revenue Market Share by Manufacturer in 2017
Table Mexico Microbiome Therapeutics Export and Import (2013-2018)
Figure North America Microbiome Therapeutics Sales, Revenue and Growth Rate (2018-2023)
Table North America Microbiome Therapeutics Sales Forecast by Countries (2018-2023)
Table North America Microbiome Therapeutics Market Share Forecast by Countries (2018-2023)
Figure United States Microbiome Therapeutics Sales Forecast (2018-2023)
Figure Canada Microbiome Therapeutics Sales Forecast (2018-2023)
Figure Mexico Microbiome Therapeutics Sales Forecast (2018-2023)
Table North America Microbiome Therapeutics Sales Forecast by Type (2018-2023)
Table North America Microbiome Therapeutics Market Share Forecast by Type (2018-2023)
Table North America Microbiome Therapeutics Sales Forecast by Application (2018-2023)
Table North America Microbiome Therapeutics Market Share Forecast by Application (2018-2023)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Microbiome Therapeutics
Figure Manufacturing Process Analysis of Microbiome Therapeutics
Figure Microbiome Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of Microbiome Therapeutics Major Manufacturers in 2017
Table Major Buyers of Microbiome Therapeutics
Table Distributors/Traders/ Dealers List
  • Global Vasculitis Treatment Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 25-Sep-2018        Price: US 3480 Onwards        Pages: 136
    Vasculitis is a general term that refers to inflammation of blood vessels. When blood vessels become inflamed, they may become weakened, stretch, and either increase in size or become narrow -- even to the point of closing entirely.- Vasculitis can affect people of all ages, but there are types of vasculitis that occur in certain age groups more often than others. Scope of the Report: This report focuses on the Vasculitis Treatment in global market, especially in No......
  • Global Light Therapy Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 24-Sep-2018        Price: US 3480 Onwards        Pages: 115
    Light therapy consists of exposure to daylight or to specific wavelengths of light using polychromatic polarised light, lasers, light-emitting diodes, fluorescent lamps, dichroic lamps or very bright, full-spectrum light. The light is administered for a prescribed amount of time and, in some cases, at a specific time of day. Scope of the Report: This report studies the Light Therapy market status and outlook of Global and major regions, from angles of players, countries, pr......
  • Global Thyroid Gland Disorder Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 19-Sep-2018        Price: US 3480 Onwards        Pages: 123
    Hormones released by thyroid gland play a crucial role in stimulating metabolism, growth, and calories processing. Globally, thyroid gland disorders such as hypothyroidism, hyperthyroidism, and thyroid nodules affect around 5% to 10% of the population. Hyperthyroidism and hypothyroidism affect majority of the population primarily due to growing incidence of autoimmune diseases such as Grave's disease and Hashimoto's thyroiditis. Moreover, iodine deficiency is a widespread problem across the glob......
  • 2018-2023 Global Enzyme Replacement Therapy Market Report (Status and Outlook)
    Published: 18-Sep-2018        Price: US 4660 Onwards        Pages: 132
    In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Enzyme Replacement Therapy market for 2018-2023. Enzyme replacement therapy (ERT) is a medical treatment which replaces an enzyme that is deficient or absent in the body. Usually, this is done by giving the patient an intravenous (IV) infusion of a solution containing the enzyme. The classification of enzyme replacement therapy includes injectable a......
  • Global Varicose Vein Treatment Market Insights, Forecast to 2025
    Published: 18-Sep-2018        Price: US 3900 Onwards        Pages: 124
    This report studies the global market size of Varicose Vein Treatment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Varicose Vein Treatment in these regions. This research report categorizes the global Varicose Vein Treatment market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, mark......
  • 2018-2023 Global Digital Therapeutics & Wellness Market Report (Status and Outlook)
    Published: 18-Sep-2018        Price: US 4660 Onwards        Pages: 157
    In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Digital Therapeutics & Wellness market for 2018-2023. Digital Therapeutics is an innovative new class of medicine that gives participants access to the world's most effective behavior therapies, enhanced with smart technology, and delivered directly to their fingerprints or front door. Digital therapeutics may be up and coming, but they also have a ......
  • Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2018
    Published: 18-Sep-2018        Price: US 2000 Onwards        Pages: 498
    Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2018, provides an overview of the Graft Versus Host Disease (GVHD) (Immunology) pipeline landscape. Graft-versus-host disease (GVHD) is a complication that can occur after a stem cell or bone marrow transplant in which the newly transplanted donor ......
  • Psoriasis - Pipeline Review, H2 2018
    Published: 18-Sep-2018        Price: US 2500 Onwards        Pages: 726
    Psoriasis - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Psoriasis - Pipeline Review, H2 2018, provides an overview of the Psoriasis (Immunology) pipeline landscape. Psoriasis is a chronic skin condition caused by an overactive immune system. Symptoms of the disease include shedding of cells, flared up skin, itchiness, and burning sensation, swollen and stiff joints. Predisposing ......
  • 2018-2023 Global Infantile Spasms Therapeutics Consumption Market Report
    Published: 18-Sep-2018        Price: US 4660 Onwards        Pages: 130
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Infantile Spasms Therapeutics market for 2018-2023. An infantile spasm (IS), also known as West Syndrome, is a specific type of seizure seen in an epilepsy syndrome of infancy and childhood. West Syndrome is characterized by infantile spasms, developmental regression, and a specific pattern on electroencephalography (EEG) testing called hypsarrhythmia (chao......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs